Latest SQ109 Stories
MOSCOW, February 13, 2014 /PRNewswire/ -- Russian and Korean biotech companies Infectex Ltd. [http://www.infectex.ru/?ln=en ] and Qurient Ltd.
Anti-Fungal, Additional Mycobacterial Indications Among Those Targeted ROCKVILLE, Md., Nov.
ROCKVILLE, Md., May 5 /PRNewswire/ -- Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, announced today the start of its Phase 1B trial for SQ109 with the dosing of the first cohort of volunteers.
- The governor of a province or people.